This week's FierceBiotech is brought to you by Rho.
Hi Colleague,
The failure rate of clinical studies in depression is high, and placebo response is often blamed. In this article, Dr. Jack Modell, a board-certified psychiatrist with more than 35 years of experience in clinical research and patient care, discusses why there is more to the story than placebo response, including:
Inclusion of subjects who have depressive symptoms, but do not truly meet the criteria for major depressive disorder
Unreliability of human raters
Improperly defined study objectives
Additionally, Dr. Modell addresses steps that can be taken to avoid these pitfalls.
Download the article here:
We hope you find this article helpful. Please contact us if you would like to talk with Dr. Modell or our other experts about any concerns or questions you may have regarding your development program.
Rho, Inc. 6330 Quadrangle Drive Chapel Hill, NC 27517 United States
Want to reach 150,000+ FierceBiotech subscribers with your own message? Contact aalcover@fiercemarkets.com or call 202-824-5074.
About this email: In order to receive FierceBiotech for free, we ask that you accept an occasional email promotion from our sponsors. We carefully screen each promotion and never sell or give away your personal information. If you do not want to receive these messages, you can unsubscribe entirely from FierceBiotech. Click here to unsubscribe.
